TRACE METALS IN CYSTIC FIBROSIS

Authors:
  • MCM. VAN Caillie‐Bertrand
    M. VAN Caillie‐Bertrand
  • FBF. DE Biéville
    F. DE Biéville
  • HNH. Neijens
    H. Neijens
  • KKK. Kerrebijn
    K. Kerrebijn
  • JFJ. Fernandes
    J. Fernandes
  • HDH. Degenhart
    H. Degenhart

Abstract
Serum zinc and copper concentration, 24 hrs urinary zinc and copper excretion, plasma selenium and red blood cell glutathione peroxidase activity were measured in 13 cystic fibrosis patients aged 6 to 15 years. The mean serum zinc value ± S. D. (17.3 μmol/1 ± 4.6) did not differ from that of the control group (17.9 μmol/1 ± 3.1). Urinary zinc excretion in 12 out of 13 patients was within the normal range (1.53‐13.8 μmol/24 hrs). The mean serum copper ± S. D. (23.8 μmol/1 ± 4.2) was not significantly elevated as compared to the value found in the control group (19.2 μmol/1 ± 3.5), but 4 children, including 1 with documented portal hypertension, showed an urinary copper excretion >0.94 μmol/24 hrs (normal: 0.16‐0.80 μmol/24 hrs). Mean plasma selenium ± S. D. (0.84 μmol/1 ± 0.25) was significantly reduced as compared to the control group (1.0 μmol/1 ± 0.15) (ppp<0.05). It is concluded that CF children with severe dysfunction of the exocrine pancreas are at increased risk to develop symptoms of subclinical or manifest zinc and/or selenium deficiency. Appropriate supplementation should therefore systematically be considered.

This publication has 12 references indexed in Scilit: